Latest filing published 16 Jul 2013 for TAG IT PACIFIC INC, €573k.
No signal scores available.
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by Mark Dyne span 2 companies, the busiest being TAG IT Pacific Inc and Protagenic Therapeutics, Inc.\new. Over a trading history stretching from 30 May 2006 to 12 July 2013, the count stands at 9 filings.
The open-market record is one-sided, with 6 purchases worth €606k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants. 2013 to date brings 1 purchase and no sales.
Half of the purchases are above €1,742 and half below. Looking at 6 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +98.5%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 16 July 2013 with an open-market purchase (€573k) in TAG IT Pacific Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations